about
The complete genome and phenome of a community-acquired Acinetobacter baumanniiThe interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomesAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsIdentification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial PathogensRisk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control studyWhole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureusProposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.Antimicrobial stewardship in residential aged care facilities: need and readiness assessment.The success of acinetobacter species; genetic, metabolic and virulence attributes.Prokaryote-eukaryote interactions identified by using Caenorhabditis elegansStructural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome.The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression.Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery.Acinetobacter baumannii: emergence of a successful pathogenMeropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control studyDraft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210Species identification within Acinetobacter calcoaceticus-baumannii complex using MALDI-TOF MS.Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulenceAnti-infective Surface Coatings: Design and Therapeutic Promise against Device-Associated Infections.Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.Insights on virulence from the complete genome of Staphylococcus capitis.Impact of daptomycin resistance on Staphylococcus aureus virulence.Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureusStepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting.Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii PhysiologyCommon infections in diabetes: pathogenesis, management and relationship to glycaemic control.The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.Optimizing therapy for Acinetobacter baumannii.Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis.Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory systemThe benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis.Management of meningitis due to antibiotic-resistant Acinetobacter species.Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model.Medically important bacterial-fungal interactions.Treatment of Acinetobacter infections.The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
P50
Q21559675-7B2A49BB-63BC-46EA-9328-984B1B68E11BQ27011317-EAC82386-5163-46B2-9AB0-DF16870E4ED3Q27015109-DCFA2731-C88C-4E18-9A10-4A7E5CE43C11Q28264979-4492BA3B-8ACF-4767-86A8-03EF0B177E11Q28298477-ED6C1E7E-907B-40C7-AB9B-FC871FE05F59Q28740293-CA5209D4-D4A5-4805-A675-E5258FB50260Q30241838-0E141C98-2677-4353-8BD6-3B10D6E9F1B9Q30585570-EE72A623-3388-425D-86E6-B13596906AC0Q31106653-1EC5294F-0428-4E45-A96F-940137F66A0FQ33369708-E4C24BF0-DD8B-44D8-9F3C-FA1855AE5A88Q33654525-19217A71-A96B-40C5-8BD7-F945932E1360Q34229719-578BF09C-EAA4-42C1-915E-2F941F843E95Q34374275-A6519EB0-5B0E-40D0-963F-FDA3F052A6BCQ34795807-F2281B80-B028-4E0E-BE7F-D097972D3384Q35030247-608A12CF-B639-4AAC-B29B-C66F7A5F12C4Q35110090-E177AA6F-77D5-4429-8CCB-88A13569CC0AQ35722282-06AD3A0B-A564-4BC7-8A7C-501FE4354320Q35779569-C5D67E79-263C-4A17-9F17-B2C7C8A755AFQ35867270-89393882-7F22-4B20-9DE4-6684CB85ED02Q36037715-E82DA67C-16DD-4312-BECC-0F5A7EFECAFEQ36083692-A1592490-1200-41DF-A49C-F6F128A76871Q36098105-F1786B52-AE9A-4BA6-8912-DF015AE17ACBQ36147127-EE5B6653-8576-4C75-BC40-90FBA091DC12Q36153912-84ADC781-7075-4739-B8ED-6A3208A6D5A4Q36158472-28EEA941-205C-42CD-B262-EC05E2946B32Q36188141-A3040406-246A-440B-B11A-1989B9486111Q36313244-8005F0EC-C380-4D32-AFFE-2093A26BD93AQ36401160-D737D6E5-2341-4D23-AE15-AFC85DDC9595Q36439189-27C130DB-437E-4FBC-A963-969BB534631DQ36589117-769DBEA6-4EE2-4ACC-91E8-53D1E7EA253FQ36787486-05DFD515-EA41-4B7C-9D22-990EA3BBAB35Q37038607-EABFF853-1EAB-4C96-9731-5CB8AFEC5821Q37213637-EA39A0A3-A578-426E-9FCE-722C6BF15CBBQ37236231-1321D107-B94F-4868-B6EC-7B7F59F25CE0Q37336257-07B756F5-53DF-45C7-94AA-1B8317C20BF2Q37382976-B76860FF-A922-405A-96FC-1FE0F712D7C2Q37410095-611A01DF-1874-4F23-94A1-D9C893367E3BQ37720396-CB7E5B4A-AC52-4F4F-9422-8940B55098B2Q37760952-6B5E5511-6BAB-4CF0-AEF1-6725C78C68C3Q38097310-AA8C14E9-F614-4F28-8266-32B82D621135
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anton Y. Peleg
@ast
Anton Y. Peleg
@en
Anton Y. Peleg
@es
Anton Y. Peleg
@nl
type
label
Anton Y. Peleg
@ast
Anton Y. Peleg
@en
Anton Y. Peleg
@es
Anton Y. Peleg
@nl
prefLabel
Anton Y. Peleg
@ast
Anton Y. Peleg
@en
Anton Y. Peleg
@es
Anton Y. Peleg
@nl
P106
P1153
7004675656
P21
P31
P496
0000-0002-2296-2126